These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 25581251

  • 1. Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride.
    Tack J, Camilleri M, Dubois D, Vandeplassche L, Joseph A, Kerstens R.
    Neurogastroenterol Motil; 2015 Mar; 27(3):397-405. PubMed ID: 25581251
    [Abstract] [Full Text] [Related]

  • 2. A placebo-controlled trial of prucalopride for severe chronic constipation.
    Camilleri M, Kerstens R, Rykx A, Vandeplassche L.
    N Engl J Med; 2008 May 29; 358(22):2344-54. PubMed ID: 18509121
    [Abstract] [Full Text] [Related]

  • 3. A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation.
    Yiannakou Y, Piessevaux H, Bouchoucha M, Schiefke I, Filip R, Gabalec L, Dina I, Stephenson D, Kerstens R, Etherson K, Levine A.
    Am J Gastroenterol; 2015 May 29; 110(5):741-8. PubMed ID: 25869393
    [Abstract] [Full Text] [Related]

  • 4. Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation-Quality of Life questionnaire in prucalopride (RESOLOR) trials for chronic constipation.
    Dubois D, Gilet H, Viala-Danten M, Tack J.
    Neurogastroenterol Motil; 2010 Feb 29; 22(2):e54-63. PubMed ID: 19761492
    [Abstract] [Full Text] [Related]

  • 5. Effect of prucalopride on symptoms of chronic constipation.
    Tack J, Stanghellini V, Dubois D, Joseph A, Vandeplassche L, Kerstens R.
    Neurogastroenterol Motil; 2014 Jan 29; 26(1):21-7. PubMed ID: 24106924
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation.
    Shin A, Camilleri M, Kolar G, Erwin P, West CP, Murad MH.
    Aliment Pharmacol Ther; 2014 Feb 29; 39(3):239-53. PubMed ID: 24308797
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prucalopride for the treatment of women with chronic constipation in whom standard laxative regimens have failed to provide adequate relief.
    Pennant M, Orlando R, Barton P, Bayliss S, Routh K, Meads C.
    Health Technol Assess; 2011 May 29; 15 Suppl 1():43-50. PubMed ID: 21609652
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials.
    Camilleri M, Piessevaux H, Yiannakou Y, Tack J, Kerstens R, Quigley EMM, Ke M, Da Silva S, Levine A.
    Dig Dis Sci; 2016 Aug 29; 61(8):2357-2372. PubMed ID: 27056037
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation.
    Sloots CE, Rykx A, Cools M, Kerstens R, De Pauw M.
    Dig Dis Sci; 2010 Oct 29; 55(10):2912-21. PubMed ID: 20428949
    [Abstract] [Full Text] [Related]

  • 14. Prucalopride improves bowel function and colonic transit time in patients with chronic constipation: an integrated analysis.
    Emmanuel A, Cools M, Vandeplassche L, Kerstens R.
    Am J Gastroenterol; 2014 Jun 29; 109(6):887-94. PubMed ID: 24732867
    [Abstract] [Full Text] [Related]

  • 15. Prucalopride is no more effective than placebo for children with functional constipation.
    Mugie SM, Korczowski B, Bodi P, Green A, Kerstens R, Ausma J, Ruth M, Levine A, Benninga MA.
    Gastroenterology; 2014 Dec 29; 147(6):1285-95.e1. PubMed ID: 25239590
    [Abstract] [Full Text] [Related]

  • 16. Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation -- a comparison in a controlled environment.
    Cinca R, Chera D, Gruss HJ, Halphen M.
    Aliment Pharmacol Ther; 2013 May 29; 37(9):876-86. PubMed ID: 23480216
    [Abstract] [Full Text] [Related]

  • 17. Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies.
    Camilleri M, Van Outryve MJ, Beyens G, Kerstens R, Robinson P, Vandeplassche L.
    Aliment Pharmacol Ther; 2010 Nov 29; 32(9):1113-23. PubMed ID: 21039673
    [Abstract] [Full Text] [Related]

  • 18. Prucalopride: A Review in Chronic Idiopathic Constipation.
    Garnock-Jones KP.
    Drugs; 2016 Jan 29; 76(1):99-110. PubMed ID: 26628294
    [Abstract] [Full Text] [Related]

  • 19. Prucalopride in Gastroparesis: A Randomized Placebo-Controlled Crossover Study.
    Carbone F, Van den Houte K, Clevers E, Andrews CN, Papathanasopoulos A, Holvoet L, Van Oudenhove L, Caenepeel P, Arts J, Vanuytsel T, Tack J.
    Am J Gastroenterol; 2019 Aug 29; 114(8):1265-1274. PubMed ID: 31295161
    [Abstract] [Full Text] [Related]

  • 20. [Some practical questions on chronic stipsis treatment with prucalopride].
    Bellacosa L, Cogliandro R, Cremon C, De Giorgio R, Barbara G, Stanghellini V.
    Minerva Gastroenterol Dietol; 2014 Mar 29; 60(1):85-99. PubMed ID: 24632771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.